Piracetam Acute Stroke Study II "PASS II"

Active, not recruiting

Phase 3 Results N/A

Summary of Purpose

To determine whether the early administration of piracetam in aphasic acute stroke patients will enhance recovery from aphasia at 4 and 12 weeks post-stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 April 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • UCB S.A. Belgium.

Trial Design

Double-blind, 2-parallel-group, placebo-controlled, multicenter trial.

Contacts

  • Jöel Thirot, MD Brussels, Belgium.

    j.m.orgogozo@neuro.u-bordeaux2.fr